Literature DB >> 30423045

Current Status and Trends of Antibacterial Resistance in China.

Fupin Hu1, Demei Zhu1, Fu Wang1, Minggui Wang1.   

Abstract

The bacterial resistance surveillance system is relatively well established at the national, provincial, and hospital levels in China. Two representative national surveillance networks for bacterial resistance are the China Antimicrobial Resistance Surveillance System (CARSS) and the China Antimicrobial Surveillance Network (CHINET), both established in 2005. CARSS data show the different bacterial resistance rates among different provinces and autonomous regions for each specific bacterium. CHINET data mainly represent the bacterial resistance profiles of teaching hospitals and show the changing trends of bacterial resistance in China. For clinical isolates, the ratio of gram-negative bacilli to gram-positive cocci is approximately 7 to 3. In general, gram-negative bacilli have higher antimicrobial resistance profiles in China. Regarding different bacterial species, antimicrobial resistance is multifaceted. The prevalence of extended-spectrum β-lactamases is high; Acinetobacter baumannii has a high antimicrobial resistance profile; and, notably, the prevalence of CRKP has been showing a marked increase since 2005. In addition, the prevalence of vancomycin-resistant Enterococcus is low, and the prevalence of methicillin-resistant Staphylococcus aureus and antimicrobial resistance in Pseudomonas aeruginosa showed decreasing trends from 2005 to 2017.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30423045     DOI: 10.1093/cid/ciy657

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  70 in total

1.  Rapid Increase in Carbapenemase-Producing Enterobacteriaceae in Retail Meat Driven by the Spread of the bla NDM-5-Carrying IncX3 Plasmid in China from 2016 to 2018.

Authors:  Qianhui Zhang; Luchao Lv; Xiuyu Huang; Ying Huang; Zilin Zhuang; Jiaxun Lu; Enyu Liu; Miao Wan; Haoliang Xun; Zhiwei Zhang; Jin Huang; Qianhua Song; Chao Zhuo; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Clinical and molecular characteristics of Staphylococcus aureus isolated from Chinese children: association among the agr groups and genotypes, virulence genes and disease types.

Authors:  Yan Xu; Su-Yun Qian; Kai-Hu Yao; Fang Dong; Wen-Qi Song; Chen Sun; Xin Yang; Jing- Hui Zhen; Xi-Qing Liu; Zhi -Yong Lv; Xi Yang
Journal:  World J Pediatr       Date:  2021-03-03       Impact factor: 2.764

3.  Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

Authors:  Minggui Wang; Michelle Earley; Liang Chen; Blake M Hanson; Yunsong Yu; Zhengyin Liu; Soraya Salcedo; Eric Cober; Lanjuan Li; Souha S Kanj; Hainv Gao; Jose M Munita; Karen Ordoñez; Greg Weston; Michael J Satlin; Sandra L Valderrama-Beltrán; Kalisvar Marimuthu; Martin E Stryjewski; Lauren Komarow; Courtney Luterbach; Steve H Marshall; Susan D Rudin; Claudia Manca; David L Paterson; Jinnethe Reyes; Maria V Villegas; Scott Evans; Carol Hill; Rebekka Arias; Keri Baum; Bettina C Fries; Yohei Doi; Robin Patel; Barry N Kreiswirth; Robert A Bonomo; Henry F Chambers; Vance G Fowler; Cesar A Arias; David van Duin
Journal:  Lancet Infect Dis       Date:  2021-11-09       Impact factor: 25.071

4.  Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Dongmei Lv; Yan Zuo; Yuerong Wang; Zhongxin Wang; Yuanhong Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-20       Impact factor: 6.073

5.  Comparative In Vitro Activities of Ceftaroline and Tedizolid against Clinical Strains of Staphylococcus aureus and Enterococcus: Results from the China Antimicrobial Surveillance Network (CHINET) in 2018.

Authors:  Yan Guo; Yang Yang; Yonggui Zheng; Shi Wu; Dandan Yin; Demei Zhu; Fupin Hu
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

6.  Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073.

Authors:  Ying Sun; Xueyuan Liao; Zhigang Huang; Yaliu Xie; Yanbin Liu; Cuicui Ma; Boguang Jiang; Li Zhang; Yuhang Yan; Guobo Li; Xingjun Cheng; Qi Yin; Charles Z Ding; Liang Shen; Jian Li; Shuhui Chen; Yuquan Wei; Zhenling Wang; Xiawei Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 7.  Sonobactericide: An Emerging Treatment Strategy for Bacterial Infections.

Authors:  Kirby R Lattwein; Himanshu Shekhar; Joop J P Kouijzer; Willem J B van Wamel; Christy K Holland; Klazina Kooiman
Journal:  Ultrasound Med Biol       Date:  2019-11-05       Impact factor: 3.694

8.  Different Infection Profiles and Antimicrobial Resistance Patterns Between Burn ICU and Common Wards.

Authors:  Yali Gong; Yuan Peng; Xiaoqiang Luo; Cheng Zhang; Yunlong Shi; Yixin Zhang; Jun Deng; Yizhi Peng; Gaoxing Luo; Haisheng Li
Journal:  Front Cell Infect Microbiol       Date:  2021-06-30       Impact factor: 5.293

9.  Pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose intravenous ceftobiprole in healthy Chinese participants.

Authors:  Wan-Zhen Li; Hai-Lan Wu; Yuan-Cheng Chen; Bei-Ning Guo; Xiao-Fen Liu; Yu Wang; Ju-Fang Wu; Jing Zhang
Journal:  Ann Transl Med       Date:  2021-06

10.  Validation and Extrapolation of a Multimodal Infection Prevention and Control Intervention on Carbapenem-Resistant Klebsiella pneumoniae in an Epidemic Region: A Historical Control Quasi-Experimental Study.

Authors:  Yunqi Dai; Tianjiao Meng; Xiaoli Wang; Bin Tang; Feng Wang; Ying Du; Yuzhen Qiu; Jialin Liu; Ruoming Tan; Hongping Qu
Journal:  Front Med (Lausanne)       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.